Your session is about to expire
← Back to Search
Growing-up Formula
Growing Up Formula vs Nutritional Supplements for Toddler Malnutrition (KEEP Growing Trial)
N/A
Recruiting
Led By Liliane Diab, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy toddlers 12-36 months of age with mild or moderate malnutrition meeting at least one of the following indicators: Weight-for-length z-score between -1.0 and -2.9 for children less than 2 years of age using the WHO growth standards, BMI z-score between -1 to -2.9 for children between 2 and 3 years of age using the CDC growth standards, Middle upper-arm circumference (MUAC) z-scores between -1 to -2.9 using the WHO growth references, Percentage of median ideal body weight of 70-89% using growth standards.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 months
Awards & highlights
KEEP Growing Trial Summary
This trial will compare a growing-up formula to a common nutritional supplement to see if the GUF helps picky eaters increase solid food intake and improve growth.
Who is the study for?
This trial is for toddlers aged 12-36 months with mild to moderate malnutrition, as indicated by specific growth measurements like weight-for-length or BMI z-scores. It's aimed at those who may not eat enough solid foods and need nutritional support.Check my eligibility
What is being tested?
The study compares a growing-up formula (Enfagrow) with a common children's nutritional supplement (Pediasure). The goal is to see if Enfagrow can help these toddlers eat more solid food and improve their growth compared to Pediasure.See study design
What are the potential side effects?
Potential side effects are not specified in the provided information but could include digestive issues such as constipation or diarrhea, allergic reactions, or changes in appetite.
KEEP Growing Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My toddler is mildly or moderately malnourished according to health standards.
KEEP Growing Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Dietary intake from solid foods - Total grains in grams
Dietary intake from solid foods - Total proteins in grams
Dietary intake from solid foods - Total vegetables in cups
Secondary outcome measures
Measures Related to Growth and Nutrition
Measures Related to Growth and Nutrition -- Weight gain
KEEP Growing Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Growing Up Formula (GUF)Experimental Treatment1 Intervention
Group II: Standard Nutritional Supplement (NS)Active Control1 Intervention
Find a Location
Who is running the clinical trial?
Children's Hospital ColoradoOTHER
116 Previous Clinical Trials
5,132,465 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,376 Total Patients Enrolled
9 Trials studying Malnutrition
9,383 Patients Enrolled for Malnutrition
Mead Johnson NutritionIndustry Sponsor
79 Previous Clinical Trials
16,218 Total Patients Enrolled
2 Trials studying Malnutrition
341 Patients Enrolled for Malnutrition
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My toddler is mildly or moderately malnourished according to health standards.
Research Study Groups:
This trial has the following groups:- Group 1: Growing Up Formula (GUF)
- Group 2: Standard Nutritional Supplement (NS)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger